Cisplatin and gemcitabine plus ramucirumab or merestinib or placebo in first-line treatment for advanced or metastatic biliary tract cancer: a double-blind, randomized phase 2 trial.
Bousmans, N Zhang, W Walgren, R Vogel, A
Bousmans, N
Zhang, W
Walgren, R
Vogel, A
Citations
Altmetric:
Abstract
Description
Date
2016-10-01
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Cisplatin and gemcitabine plus ramucirumab or merestinib or placebo in first-line treatment for advanced or metastatic biliary tract cancer: a double-blind, randomized phase 2 trial. 2016, 27(suppl_6):712TiP Annals of Oncology